Company profile: Boston Heart Diagnostics
1.1 - Company Overview
Company description
- Provider of cardiovascular disease management solutions, combining proprietary lipid testing, advanced diagnostics, therapy guidelines, and patient support. Offerings include CVMap, Polygenic Risk Map, LipoMap NMR lipid panel, dried blood spot testing with 40+ assays, advanced lipid tests for risk stratification and chronic care, and a tailored lifestyle program for long-term health.
Products and services
- CVMap: An advanced diagnostic system that combines standard lipid assessments with advanced diagnostics to deliver detailed insights into cardiovascular disease risk for physicians and patients
- LipoMap: An NMR-based panel of 33 lipid and lipoprotein tests using high-resolution instruments to assess lipid metabolism and characterize cardiovascular risk profiles
- Advanced Lipid Tests: An exclusive portfolio of tests and methodologies engineered for cardiovascular risk stratification and chronic care management
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Boston Heart Diagnostics
Rhythmia
HQ: United States
Website
- Description: Provider of medical devices for treating cardiac arrhythmia, focusing on development of a 3D cardiac mapping system to improve catheter ablation procedures for tachy-arrhythmias, such as atrial fibrillation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rhythmia company profile →
Endologix
HQ: United States
Website
- Description: Provider of minimally invasive treatments for aortic disorders, offering the AFX2 Endovascular AAA System for abdominal aortic aneurysms with specific aneurysm morphology; the ALTO Abdominal Stent Graft System for infrarenal abdominal aortic aneurysms requiring specific vascular morphology; and the DETOUR System for percutaneous revascularization of symptomatic femoropopliteal lesions in patients suboptimal for surgical or alternative endovascular treatments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Endologix company profile →
Ablative Solutions
HQ: United States
Website
- Description: Provider of an alternative to surgical renal denervation for hypertension, offering the Peregrine System Kit, a transcatheter alcohol-mediated system delivering neurolytic solution to the perivascular space of the renal artery; the Peregrine System Infusion Catheter with three guided microneedles for targeted infusion into the perivascular area of the peripheral vasculature; and the TARGET BP clinical trials evaluating safety and efficacy for uncontrolled hypertension.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ablative Solutions company profile →
Adagio Medical
HQ: United States
Website
- Description: Provider of research and development focused on creating treatments for cardiovascular diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adagio Medical company profile →
Vascular Dynamics
HQ: United States
Website
- Description: Provider of the MobiusHD endovascular implant and catheter-based EVBA procedure to modulate the baroreflex via carotid sinus placement, aiming to correct inflexible arterial motion to treat hypertension and restore autonomic balance in heart failure patients; also conducts clinical research evaluating the safety and effectiveness of MobiusHD.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vascular Dynamics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Boston Heart Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Boston Heart Diagnostics
2.2 - Growth funds investing in similar companies to Boston Heart Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Boston Heart Diagnostics
4.2 - Public trading comparable groups for Boston Heart Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →